Online Courses

Designed by SOGC experts and employing the most current medical knowledge, our accredited online courses combine premier medical education with the convenience of online study. 

These courses are designed specifically for improving the learning experience and to tailor your educational experiences to meet your personal learning objectives.

Courses

Courses
This program reviews current knowledge in the safety and best practices in minimally invasive surgery, particularly surgical approaches to laparoscopy, fluid management, and electrosurgery in gynaecology.  Laparoscopic entry techniques have evolved in the understanding of variations in underlying anatomy with implications for device placement and technique. Fluid management during diagnostic or operative hysteroscopy is a balance that involves careful decisions about the type of fluid media, monitoring, and interventions to facilitate surgery while preventing or managing perfusion into the peritoneal cavity or fluid overload. Electrosurgery in gynaecology allows sophisticated approaches to tissue modulation.    This program supports specialists in gynaecology in their knowledge of these aspects of minimally invasive surgery with an individualized understanding of patient risks and benefits.
This online course will give you the opportunity to evaluate twenty cases of women seeking contraception. These will present common and not-so-common situations that may face health care providers. This Assessment program has been certified by the College of Family Physicians of Canada for up to 3 Mainpro+ credits. This event is a Self-Assessment (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Society of Obstetricians and Gynaecologists of Canada. You may claim a maximum of 3 hour (credits are automatically calculated). Once you register to the course, you will receive a link via email. This can take up to 24 hours. Thank you for your understanding
The objectives of this course are to allow participants to: - Review the epidemiology of HPV and disease - Update the latest data on HPV vaccines - Discuss the uptake of HPV vaccination and its impact on disease - Explore the safety of HPV vaccines - Learn how to successfully counsel on HPV vaccination
The objectives of this course are to allow participants to: Review the rational of using aromatase inhibitor in infertility Update the latest data on letrozole Discuss indications and safety of letrozole treatment Discuss how to use letrozole in infertility Learn how to counsel the patients about letrozole treatment
 
By the end of this presentation, you should be able to: Define medical abortion Describe the incidence of both induced abortion and medical abortion in Canada Identify differences in abortion access between and within the provinces and territories Understand the need for a combination regimen of mifepristone/misoprostol in Canada This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada. You may claim a maximum of 6 hours This program has been accredited by the College of Family Physicians of Canada for up to 6 Mainpro-M1 credits and with The Canadian Council on Continuing Education in Pharmacy (CCCEP) for 3 CEU credits.
The medical management of uterine fibroids is an evolving practice. As novel therapies are introduced, clinical practice guidance has been updated to provide evidence-based recommendations on the evolving role of these agents in clinical practice. This program reviews the role of medical therapy in the management of uterine fibroids. The Society of Obstetricians and Gynaecologists of Canada (SOGC) provides guidance for The Management of Uterine Leiomyomas (SOGC CPG #318).1   Additional SOGC guidance of relevance to this topic includes: Abnormal Uterine Bleeding in Pre-Menopausal Women2 The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility3   “Until recently, medical management options for uterine leiomyomas have been of limited value because of their moderate efficacy and/or associated adverse effects. Novel therapies at the receptor and gene levels have emerged or are undergoing investigation and may eventually offer better long-term management options.”1 -- SOGC Clinical Practice Guideline #318
As the population ages, women with menopausal symptoms make up an increasing proportion of the population. Vasomotor and vaginal symptoms in menopause are common. Additionally, menopause is associated with other changes including decreased bone density, joint pain, sleep disturbance and increased cardiovascular risk. Overall, menopause can affect quality of life, sexuality, self-image, and health status.  It is important to ask women if they are experiencing symptoms, since many may think that menopausal symptoms are just a natural consequence of menopause and something they must suffer through. Many may also mistakenly feel that therapy is not an option due to safety concerns. The scientific evidence and the therapeutic options have changed since WHI. This program supports physicians with the individualized management of menopause-related symptoms and conditions, in accordance with SOGC clinical practice guidelines, for improved patient outcomes.